SCHEMBL25645973

SCHEMBL25645973

c1ccc(-c2ccc(-c3nc(-c4cccc(-c5cccc6sc7ccccc7c56)c4)nc(-c4cccc5oc6ccccc6c45)n3)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRDT Q58F21 1/20 0.34
PLA2G2A P14555 3/20 0.33
PLA2G4A P47712 3/20 0.33
LIMK1 P53667 1/20 0.33
ALOX5 P09917 2/20 0.33
BACE1 P56817 1/20 0.32
MAPT P10636 2/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
TP53 P04637 1/20 0.32
HPGD P15428 1/20 0.32
TSHR P16473 1/20 0.32
NFKB1 P19838 1/20 0.32
MAPK1 P28482 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32
ATM Q13315 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HSD17B10 Q99714 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23820792 0.98 BRDT (0.35) BRDTLIMK1ALOX5BACE1MAPT
SCHEMBL21147391 0.97 PLA2G2A (0.36) BRDTPLA2G2APLA2G4ALIMK1ALOX5
SCHEMBL21147390 0.97 PLA2G2A (0.36) BRDTPLA2G2APLA2G4ALIMK1ALOX5
SCHEMBL23820482 0.96 S1PR5 (0.36) BRDTLIMK1ALOX5BACE1MAPT
SCHEMBL23820294 0.96 PRKDC (0.35) BRDTPLA2G2APLA2G4ALIMK1ALOX5
SCHEMBL23821618 0.95 BACE1 (0.35) BRDTLIMK1BACE1MAPTKDM4E
SCHEMBL25645971 0.95 BACE1 (0.35) BRDTLIMK1BACE1MAPTKDM4E
SCHEMBL21168092 0.95 BRDT (0.36) BRDTPLA2G2APLA2G4ALIMK1ALOX5
SCHEMBL19802130 0.95 PLA2G2A (0.34) BRDTPLA2G2APLA2G4ALIMK1ALOX5
SCHEMBL23820477 0.95 S1PR5 (0.35) BRDTLIMK1ALOX5BACE1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230165145-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230165145-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT EMITTING DEVICE CRY1, CYP1A1, CYP1B1 BRDT 2677/4885PLA2G2A 3909/4885PLA2G4A 3952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.